Navigation Links


Corticotropin in Medical News

Questcor and Child Neurology Foundation Announce Creation of Infantile Spasms Awareness Week

...r Pharmaceuticals Questcor Pharmaceuticals, Inc. is a pharmaceutical company that markets two commercial products, H.P. Acthar((R)) Gel (repository corticotropin injection) and Doral((R)) (quazepam tablets, USP). Acthar is an injectable drug that is approved for the treatment of certain disorders with an inflam...

Neurocrine Biosciences Reports Fourth Quarter and Year-End 2008 Results

...crine is also investigating the potential of certain GnRH antagonists in treating other hormone-dependent diseases in men's and women's health. corticotropin Releasing Factor (CRF1) Receptor Antagonists for Anxiety/Depression and IBS The CRF collaboration between Neurocrine and GSK has identified mul...

Yerkes researchers create animal model of chronic stress

...ber of behavioral changes and physical health problems, including anxiety, depression and infertility." Via the animal model, the researchers found corticotropin releasing factor (CRF) is a key neurohormone involved in stress response. Wilson explains, "CRF is located in several different brain regions, serving...

Rat Study Gets at Root of Nicotine Addiction

...t to better drugs that can help smokers kick the habit. In rats, chronic nicotine use recruits a major brain stress system -- the extrahypothalamic corticotropin releasing factor (CRF) system. This contributes to continued nicotine use by exacerbating anxiety and craving whenever nicotine is withdrawn, the rese...

Being Sad Can Kill You

... saliva tests and their moods were assessed using psychiatric tests. It was seen that there were significantly higher levels of the stress hormone corticotropin –releasing hormone (CRH) in the depressed women. It was also seen that significantly, the length of pregnancy in average, was much shorter in depr...
Corticotropin in Medical Technology

Neurocrine Biosciences Reports First Quarter 2008 Results

...Neurocrine is also investigating the potential of certain GnRH antagonists in treating other hormone-dependent diseases in Men's and Women's Health. corticotropin Releasing Factor (CRF1) Receptor Antagonists for Anxiety/Depression and IBS The CRF collaboration between Neurocrine and GSK has identified multiple...

Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results

...RH antagonists in treating other hormone-dependent diseases in Men's and Women's Health. Partnership discussions are ongoing for our GnRH program. corticotropin Releasing Factor (CRF1) Receptor Antagonists in Mood Disorders and IBS. -- GSK has recently completed a Phase II "proof of concept" clinical trial...
Corticotropin in Medical Dictionary

ACTH

...thologies du baillement, la ... Behavioral effects induced by intracisternally injected ACTH and MSH ... ACTH (Adrenocorticotropic hormone) or corticotropin is a 39-amino acid peptide ... ACTH secretion from the anterior pituitary is ... List of 14 disease causes of Low ACTH , patient stories,...
Corticotropin in Biological News

How the brain learns to become addicted

...t of behaviors associated with drug-craving in human addicts. The latest findings follow an earlier discovery by the same group that another molecule, corticotropin releasing factor (CRF), acts similarly. Such adaptations are believed to create a need that is far more compelling than the simple memory of drug-i...
Corticotropin in Biological Technology

Neurocrine Biosciences Reports First Quarter 2009 Results

...ny continues to investigate the potential of certain GnRH antagonists in treating other hormone-dependent diseases in men's and women's health. corticotropin Releasing Factor (CRF1) Receptor Antagonists for Anxiety/Depression and IBS The CRF collaboration between Neurocrine and GSK has identified mul...

Neurocrine Biosciences Reports Third Quarter 2008 Results

...Neurocrine is also investigating the potential of certain GnRH antagonists in treating other hormone-dependent diseases in Men's and Women's Health. corticotropin Releasing Factor (CRF1) Receptor Antagonists for Anxiety/Depression and IBS The CRF collaboration between Neurocrine and GSK has identified multiple...

Neurocrine Biosciences Reports Second Quarter 2008 Results

...Neurocrine is also investigating the potential of certain GnRH antagonists in treating other hormone-dependent diseases in Men's and Women's Health. corticotropin Releasing Factor (CRF1) Receptor Antagonists for Anxiety/Depression and IBS The CRF collaboration between Neurocrine and GSK has identified multiple...
Corticotropin in Biological Definition

Neurotransmitter

... neurophysin I neurophysin II Neuropeptide Y: neuropeptide Y (NY) pancreatic polypeptide (PP) peptide YY (PYY) Opioids : corticotropin (ACTH) Beta-lipotropin dynorphin endorphin enkephaline leumorphin Secretins: secretin motilin glucagon vasoactive...
Other TagsReaderReaderReaderFlyingEntrepreneurshipBioSystemBioSystemHouseHouseHouseHouseEconomicEconomic
Breaking Medicine News(10 mins):Health News:New study finds low rate of injuries at overnight summer camp 2Health News:DNA Test May Detect Immune Disorder in Infants 2Health News:Soy Beneficial for Breast Cancer Survivors: Study 2Health News:Soy Beneficial for Breast Cancer Survivors: Study 3Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 2Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 3Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 4Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 5Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 6Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 7Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 8Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 9Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 10Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 11Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 12Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 13Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 14Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 15Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 16Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 17Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 18Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 19Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 20Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 21Health News:Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends) 2Health News:Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends) 3Health News:Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends) 4Health News:Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends) 5Health News:Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends) 6
Other Contentsstutteringstyabuseabuseabuseabuseabuseabuseabusesubstancesubstancesubstancesubstancesubstancesubstancesubstancesubstancesubstancesubungualsubduralsubluxationsunburnsunburn